Results 121 to 130 of about 921,979 (317)

Abnormal negative feedback processing in first episode schizophrenia: evidence from an oculomotor rule switching task [PDF]

open access: yes, 2011
Background. Previous studies have shown that patients with schizophrenia are impaired on executive tasks, where positive and negative feedbacks are used to update task rules or switch attention.
Andreasen   +8 more
core   +1 more source

Schizophrenia is a TH2 dominant autoimmune disease possibly against acetylcholine receptors of CNS [PDF]

open access: yes, 2012
Schizophrenia is a very common psychiatric disorder. However, its etiology and pathogenesis is still unknown. Current theory saying that neurotransmitter imbalance such as serotonin or dopamine only provides limited effectiveness in schizophrenia ...
Wanchung(Wan-Jiung) Hu
core   +1 more source

Subanesthetic ketamine treatment promotes abnormal interactions between neural subsystems and alters the properties of functional brain networks [PDF]

open access: yes, 2014
Acute treatment with subanesthetic ketamine, a non-competitive N-methyl-D-aspartic acid (NMDA) receptor antagonist, is widely utilized as a translational model for schizophrenia. However, how acute NMDA receptor blockade impacts on brain functioning at a
A Bifone   +77 more
core   +1 more source

Poor self-reported sleep is associated with prolonged white matter T2 relaxation in psychotic disorders

open access: yesFrontiers in Psychiatry
BackgroundPsychotic disorders are characterized by white matter (WM) abnormalities; however, their relationship with the various aspects of illness presentation remains unclear.
Umit Haluk Yesilkaya   +13 more
doaj   +1 more source

What does a mouse tell us about neuregulin 1 – cannabis interactions?

open access: yesFrontiers in Cellular Neuroscience, 2013
The link between cannabis and psychosis has been debated although there is substantial epidemiological evidence showing that cannabis increases the risk of psychosis.
Tim eKarl   +5 more
doaj   +1 more source

What is schizophrenia?

open access: yesSchizophrenia bulletin, 2019
Many who pick up this book will be learning about schizophrenia for the first time, either because someone they care about has recently been diagnosed, or purely out of academic interest.
J. S. Strauss   +3 more
semanticscholar   +1 more source

Prevalence & Prescription: Prescribing Practices of Clozapine in Australia between 2005 & 2010 [PDF]

open access: yes, 2012
Clozapine is an anti-psychotic used to treat refractory schizophrenia. This study reviews the rates of clozapine prescription for refractory schizophrenia in a region of Australia and compares the prescribing patterns to the estimated prevalence rates of
Pai, NB, Vella, SC
core   +2 more sources

Pdxdc1 modulates prepulse inhibition of acoustic startle in the mouse. [PDF]

open access: yes, 2017
Current antipsychotic medications used to treat schizophrenia all target the dopamine D2 receptor. Although these drugs have serious side effects and limited efficacy, no novel molecular targets for schizophrenia treatment have been successfully ...
Boutros, PC   +5 more
core   +1 more source

Correction to: Skating on thin ice: pragmatic prescribing for medication refractory schizophrenia

open access: yesBMC Psychiatry, 2019
After publication of the original article [1], the authors have notified us that there was an oversight on acknowledging funding received for the study. They would like to mention that Professor Sukhi Shergill was funded by an ERC Consolidator Award.
Derek K. Tracy   +4 more
doaj   +1 more source

Global economic burden of schizophrenia: a systematic review

open access: yesNeuropsychiatric Disease and Treatment, 2016
Background Schizophrenia is one of the top 25 leading causes of disability worldwide in 2013. Despite its low prevalence, its health, social, and economic burden has been tremendous, not only for patients but also for families, caregivers, and the wider ...
H. Chong   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy